MindMed Presents Phase 2B Study of Mm120 for Generalized Anxiety Disorder (Gad) at American Psychiatric Association (Apa) Annual Meeting in New York
MindMed在纽约美国精神病学协会(Apa)年会上公布了针对广泛性焦虑症(Gad)的Mm120的2B期研究
MindMed Presents Phase 2B Study of Mm120 for Generalized Anxiety Disorder (Gad) at American Psychiatric Association (Apa) Annual Meeting in New York
MindMed在纽约美国精神病学协会(Apa)年会上公布了针对广泛性焦虑症(Gad)的Mm120的2B期研究
使用浏览器的分享功能,分享给你的好友吧